Reduction of blood oxygen shows no signs of returning to Apple Watch early
Apple removed blood oxygen monitoring from Apple Watch at the beginning of 2024. Someone has returned to him, and it looks like neither Masimo nor Apple is not go to the budget.
Monitoring of oxygen in the blood, sometimes considered pulse oxymmetry, is a non -invasive way to measure oxygen saturation (SPO2) in your blood. Apple added this to Apple Watch with Apple Watch Series 6.
That’s what we know so far.
In 2025 there was no major progress in 2025. The date of return is one of the most commonly asked questions we get.
There was sometimes hope in February 2025. Masimo then and the and adede that Katie Szyman became her temporary CESO.
Several analysts have predicted that she will be less vindictive than the previous CEO and is more willing to deal with Apple. Months have passed and it does not seem to be the case.
The last 7 July Apple claimed the US Apsals court that the ban should never be introduced and that he wants him to turn over.
During hearing before the panel of three judges, the judges seemed to be potential compassionate with the Argument of Apple. Apple Lawyer, Joseph Mueller, begged that at the time of the Masimoho device, that the patent was based on a hypothetical.
Masimo, race, argued in opposition and said Apple was trying to “rewrite the rules”. Masimo also served that Apple hid hired a key talent that gave him an advantage because Thesy knew the consecrated secrets of his blood oxygen monitor.
Finally, Masimo launched his own pulse oxymmetry wearable, W1, in 2022. Apple suesed the similarities of design.
This launch was two years after the Apple Watch with Apple Watch Series 6.
A suit against Masimo didn’t go well. In October 2024, Apple won $ 250. To be absolutely clear, Apple got two fifty dollars from the suit.
Five -year -old saga, nagoing
It all stems from a patent dispute, first selected by Masimo against Apple. It was a confusing time when Apple Ferghtoval patent and the ban on the weekend came back and Fortth.
After ITC finally decided in favor of Massimo, Apple’s only option was to stop selling Apple watch in the US or remove this feature. In January 2024 he decided for others.
At that time, any newly purchased Apple Watch Series 9 or Ultra 2 would not be allowed to function. The watch purchased before this change is still allowed.
In September 2024, Apple announced the new version of Apple Watch and did not mention the SPO2 sensor. They were Apple Watch Series 10 and the new Apple Watch Ultra 2.
While monitoring hardware still exists, both of these watches still lack the ability to perform SPO2 values.
Unclear
In the end, as the judges will rule, it remains to be seen. Since August 1, 2025, no judgment was made to dismiss Apple.
Masimo says his patent is based on hardware. That is why Apple failed to update the software to avoid the intellectual property of Masimo, beyond its deactivation.
Apple can theoretically work on new hardware changes for upcoming models. The ongoing legal challenges means its obligation to allow it through software.
Unfortunately, the forecast for return is still not great. From the initial publication we creep on the second generation of Apple Watch, which will be supplied with a deactivated function.
There are two ways for Apple. Either he gets away with Masim, or finds a new hardware solution that doesn’t rely on Masimo patents. Neith seems to be immediate.
Hardware users up to A and include Apple Watch Series 9 or Apple Watch Ultra 2, who have represented the boude before the ban, still have a functional blood oxygenation system.
The ban established for new models probably saved some hardware updates of purchases. Apple Watch has a longer spare cycle closer to the Mac cycle than iPhone, so you need to see the full impact of the deactivated function.
For now, it is a technological chicken game. Masimo or Apple must change the race and it seems not willing to do so. The accident ended the battle in the courts – it is simply not clear when.